New HIV pill trial seeks to control virus in untreated patients
NCT ID NCT07308782
Summary
This study is testing a new oral medication called CL-197 for people with HIV who have never taken any HIV drugs before. The main goal is to see how well a single dose lowers the amount of virus in the blood and to check if it is safe. Researchers will also measure how the drug moves through the body in 24 carefully selected participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV-1-INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Beijing Youan Hospital, Capital Medical University
RECRUITINGBeijing, China
Conditions
Explore the condition pages connected to this study.